Efficacy of empagliflozin in heart failure with preserved ejection fraction according to frailty status in EMPEROR-Preserved.

Coats AJS, Butler J, Tsutsui H, Doehner W, Filippatos G, Ferreira JP, Böhm M, Chopra VK, Verma S, Nordaby M, Iwata T, Nitta D, Ponikowski P, Zannad F, Packer M, Anker SD

Open source

DOI: 10.1002/jcsm.13393
Published: 2024 Feb
Container: Journal of cachexia, sarcopenia and muscle
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/jcsm.13393,
  title = {Efficacy of empagliflozin in heart failure with preserved ejection fraction according to frailty status in EMPEROR-Preserved.},
  author = {Coats AJS and Butler J and Tsutsui H and Doehner W and Filippatos G and Ferreira JP and Böhm M and Chopra VK and Verma S and Nordaby M and Iwata T and Nitta D and Ponikowski P and Zannad F and Packer M and Anker SD},
  year = {2024},
  journal = {Journal of cachexia, sarcopenia and muscle},
  doi = {10.1002/jcsm.13393},
  url = {https://doi.org/10.1002/jcsm.13393}
}

RIS

TY  - JOUR
TI  - Efficacy of empagliflozin in heart failure with preserved ejection fraction according to frailty status in EMPEROR-Preserved.
AU  - Coats AJS
AU  - Butler J
AU  - Tsutsui H
AU  - Doehner W
AU  - Filippatos G
AU  - Ferreira JP
AU  - Böhm M
AU  - Chopra VK
AU  - Verma S
AU  - Nordaby M
AU  - Iwata T
AU  - Nitta D
AU  - Ponikowski P
AU  - Zannad F
AU  - Packer M
AU  - Anker SD
PY  - 2024
JO  - Journal of cachexia, sarcopenia and muscle
DO  - 10.1002/jcsm.13393
UR  - https://doi.org/10.1002/jcsm.13393
ER  -

APA

AJS, C., J, B., H, T., W, D., G, F., JP, F., M, B., VK, C., S, V., M, N., T, I., D, N., P, P., F, Z., M, P., & SD, A. (2024). Efficacy of empagliflozin in heart failure with preserved ejection fraction according to frailty status in EMPEROR-Preserved.. Journal of cachexia, sarcopenia and muscle. https://doi.org/10.1002/jcsm.13393

Source records

pubmed · retrieved 2026-09-25T14:49:13.051Z